Fampyra is a drug that is beneficial for improving mobility in adults (over 18 years) with a walking disability due to multiple sclerosis (MS). In multiple sclerosis, inflammation damages the nerve cells’ defensive sheath leading to muscle fatigue, stiffness of the body, and trouble walking.

Fampyra (sold as Ampyra in the United States) is approved for the treatment of mobility issues by the Scottish Drugs Alliance. It treats walking disabilities in adults suffering from multiple sclerosis (MS). Fampyra contains the active compound fampridine that belongs to a group of medications called blockers of the potassium channels. They work by preventing potassium from escaping the nerve cells that have been weakened by MS. This drug helps the nervous system by making the impulses and signals reach the nerves more naturally, which encourages the patient to walk faster. Fampridine comes in the form of tablets and is to be taken orally. According to most prescriptions, patients take one tablet each in the morning and night, but most patients are given a tablet a day. Fampridine is a long-release pill that slowly extracts the medication to provide a more reliable source of fampridine.

For many patients who are currently dealing with MS symptoms, this medication may be life-changing, bringing a big difference to walking and energy levels. The Society for Multiple Sclerosis Patients in Pakistan has been helping patients arrange this medicine through Kausar Medicos Karachi to help MS patients in Pakistan with mobility issues. Just last week, we received our long-awaited supply of 4 packs of Fampyra from Karachi. We arranged these packs with the help of your donations at the cost of 15,500 per packet. Fampyra has immensely helped our patients. Our MS patients from Bahawalpur, Sheikhupura, Jhang, and Sialkot, received these medicines to help them improve mobility issues.

We thank our donors for their continued support and encourage others to donate to our cause as well.